News
Helix AI: New spin-off from IRB Barcelona, ICREA, and UPC to transform biomedical data into clinical insight using AI
2+ hour, 19+ min ago (169+ words) Highlighting IRB Barcelona's impact on society "For years, we have generated massive amounts of data in our laboratories, but we are still far from realizing its full potential. Helix AI has come about specifically to change this, enabling a more…...
The key to attacking "undruggable" proteins: IRB Barcelona reveals a breakthrough drug mechanism
1+ mon, 3+ week ago (394+ words) Highlighting IRB Barcelona's impact on society Intrinsically disordered proteins lack a fixed structure, which is why they have been considered "undruggable" targets for drug development for years. However, these proteins play a key role in numerous diseases'ranging from various types…...
Bridges to Investors " Curie. Bio, a new model for venture capital in biotech
1+ mon, 3+ week ago (142+ words) The Innovation Department is pleased to invite you to a visit from Curie. Bio on Monday, 30 March 2026. 09: 15 " 09: 30: Arrival & Coffee09: 30 " 09: 35: Welcome by Cristina Horcajada, Head of Innovation Department, IRB Barcelona09: 35 " 10: 05: Curie. Bio's Hands-On Approach to Investing in Therapeutic Startups10: 05 " 10: 30: Q&A and Coffee Networking…...
Bridging the Drug Discovery Gap: Meet and connect with Academia, Investors and Pharma
3+ mon, 1+ week ago (191+ words) The journey from a laboratory breakthrough to a life-saving treatment is complex and challenging. This session, "Bridging the Drug Discovery Gap: Meet and connect with Academia, Investors and Pharma" is designed to foster a dynamic dialogue." Navigating the development of…...